Global Onychomycosis (Tinea Unguium) Drug Competitive Landscape Professional Research Report 2024

Research Summary

Onychomycosis, also known as tinea unguium, refers to a fungal infection of the nails, most commonly affecting the toenails but can also affect the fingernails. Onychomycosis drugs, or antifungal medications, are used to treat and manage this condition. These drugs can be administered orally, topically, or through a combination of both, depending on the severity of the infection. They work by inhibiting the growth of the fungi responsible for the nail infection, ultimately leading to the elimination of the fungal presence and the restoration of healthy nail growth. Onychomycosis drugs play a crucial role in addressing a common and often persistent condition that can impact the appearance and health of the nails, and they are typically prescribed and monitored by healthcare professionals.

According to DIResearch's in-depth investigation and research, the global Onychomycosis (Tinea Unguium) Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Onychomycosis (Tinea Unguium) Drug include Pfizer, Yangtze River, Johnson & Johnson, Torrent Pharma, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, Perrigo, Galderma pharm, Zhejiang Deyer, Valeant Pharma, Moberg etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Onychomycosis (Tinea Unguium) Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Onychomycosis (Tinea Unguium) Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Onychomycosis (Tinea Unguium) Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Onychomycosis (Tinea Unguium) Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Onychomycosis (Tinea Unguium) Drug Include:

Pfizer

Yangtze River

Johnson & Johnson

Torrent Pharma

Chengdu Brilliant

Novartis

Qilu Pharmaceutical

Xiuzheng Pharmaceutical

Hubei Hengan

TARO

Perrigo

Galderma pharm

Zhejiang Deyer

Valeant Pharma

Moberg

Onychomycosis (Tinea Unguium) Drug Product Segment Include:

Oral Drug

External Drug

Onychomycosis (Tinea Unguium) Drug Product Application Include:

Age under 18

Age 18-50

Age above 50

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Onychomycosis (Tinea Unguium) Drug Industry PESTEL Analysis

Chapter 3: Global Onychomycosis (Tinea Unguium) Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Onychomycosis (Tinea Unguium) Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Onychomycosis (Tinea Unguium) Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Onychomycosis (Tinea Unguium) Drug Market Overview

1.1 Product Definition and Statistical Scope

1.2 Onychomycosis (Tinea Unguium) Drug Product by Type

1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Oral Drug

1.2.3 External Drug

1.3 Onychomycosis (Tinea Unguium) Drug Product by Application

1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Age under 18

1.3.3 Age 18-50

1.3.4 Age above 50

1.4 Global Onychomycosis (Tinea Unguium) Drug Market Revenue Analysis (2019-2030)

1.5 Onychomycosis (Tinea Unguium) Drug Market Development Status and Trends

1.5.1 Onychomycosis (Tinea Unguium) Drug Industry Development Status Analysis

1.5.2 Onychomycosis (Tinea Unguium) Drug Industry Development Trends Analysis

2 Onychomycosis (Tinea Unguium) Drug Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Regions

4.1 Onychomycosis (Tinea Unguium) Drug Overall Market: 2023 VS 2024 VS 2030

4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2019-2024)

4.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2025-2030)

5 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type and Application

5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type

5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application

6 North America

6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type

6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application

6.5 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type

7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application

7.5 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Onychomycosis (Tinea Unguium) Drug Market Size by Type

8.4 China Onychomycosis (Tinea Unguium) Drug Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Type

9.4 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Application

9.5 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type

10.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application

10.5 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type

11.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application

11.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Onychomycosis (Tinea Unguium) Drug Market Revenue by Key Manufacturers (2020-2024)

12.2 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis and Market Dynamic

12.2.1 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Pfizer

13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Yangtze River

13.2.1 Yangtze River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.3.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Torrent Pharma

13.4.1 Torrent Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.4.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Chengdu Brilliant

13.5.1 Chengdu Brilliant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Novartis

13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Qilu Pharmaceutical

13.7.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Xiuzheng Pharmaceutical

13.8.1 Xiuzheng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Hubei Hengan

13.9.1 Hubei Hengan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 TARO

13.10.1 TARO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.10.3 TARO Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Perrigo

13.11.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Galderma pharm

13.12.1 Galderma pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Zhejiang Deyer

13.13.1 Zhejiang Deyer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Valeant Pharma

13.14.1 Valeant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Moberg

13.15.1 Moberg Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Portfolio

13.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis

14.2 Onychomycosis (Tinea Unguium) Drug Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Onychomycosis (Tinea Unguium) Drug Typical Downstream Customers

14.4 Onychomycosis (Tinea Unguium) Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support